GleamWall
中文EN

MRMD MARIMED INC.

Medicinal Chemicals & Botanical Products · OTC · SEC CIK 1522767 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY6.5%
TTM net income YoY14.4%
TTM EPS YoY20.0%
Revenue 3-yr CAGR4.8%
Net income 3-yr CAGR—

Margins

Gross margin35.4%
Operating margin-1.7%
Net margin-9.3%
FCF margin5.5%
EBITDA margin3.6%

Returns

ROE-31.6%
ROA-7.7%
ROIC (approx.)-1.8%
Asset turnover0.83x

Leverage & solvency

Liabilities / assets76.3%
Debt / equity1.95x
Current ratio0.90x
Interest coverage-0.34x

Cash quality & payout

Operating cash flow / net income-0.65x
Accruals ratio-12.7%
Payout ratio—
Capex / revenue0.6%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$44.23M$41.92M$39.48M$41.65M$40.76M$39.51M$37.91M$38.95M
Cost of revenue$27.07M$25.70M$24.20M$31.15M$24.40M$23.58M$22.82M$26.29M
Gross profit$17.16M$16.23M$15.28M$10.50M$16.36M$15.93M$15.09M$12.66M
SG&A expense$6.71M$6.86M$6.89M$6.96M$6.59M$6.34M$6.25M$6.57M
Operating income$1.22M$418,000$125,000-$4.53M$1.60M$1.02M-$910,000-$1.47M
Interest expense$2.00M$2.01M$1.98M$2.15M$1.82M$1.76M$1.76M$1.89M
Pretax income-$744,000-$1.55M-$1.12M-$7.33M-$182,000-$704,000-$2.65M-$3.32M
Income tax$2.74M$2.02M$2.65M-$2.69M$2.76M$691,000$2.83M$4.95M
Net income-$3.50M-$3.59M-$3.79M-$4.63M-$2.95M-$1.39M-$5.51M-$8.27M
EBITDA$3.42M$2.72M$2.28M-$2.45M$3.70M$3.12M$897,000$693,000
EPS (basic)-0.01-0.01-0.01—-0.010.00-0.01—
EPS (diluted)-0.01-0.01-0.01—-0.010.00-0.01—
Weighted avg. shares (diluted)403.00M399.60M397.45M—392.61M389.90M382.56M—
Balance sheet
Cash & equivalents$10.36M$8.44M$7.94M$8.88M$6.60M$6.14M$7.20M$7.28M
Short-term investments———————$0
Receivables$9.18M$9.36M$9.44M$9.11M$7.96M$7.69M$9.18M$8.74M
Inventory$37.57M$36.67M$39.30M$36.60M$40.04M$38.83M$37.56M$33.49M
Current assets$61.37M$58.43M$60.79M$59.29M$60.09M$57.13M$58.00M$53.51M
PP&E, net$84.91M$86.41M$88.05M$89.39M$91.25M$92.65M$94.39M$94.17M
Goodwill$24.00M$24.00M$24.00M$24.00M$22.66M$20.05M$19.48M$15.81M
Intangibles$14.97M$15.68M$16.40M$17.21M$18.02M$20.72M$21.69M$18.64M
Total assets$198.31M$197.23M$201.19M$202.56M$205.60M$204.37M$208.00M$206.99M
Current liabilities$67.96M$63.75M$63.76M$59.07M$56.58M$50.94M$55.31M$50.01M
Long-term debt$81.89M$82.67M$82.54M$76.04M$76.24M$77.48M$77.36M$78.19M
Total debt$81.89M$82.67M$82.54M$76.04M$76.24M$77.48M$77.36M$78.19M
Total liabilities$151.33M$147.06M$147.74M$137.83M$136.55M$131.20M$134.06M$129.44M
Shareholders' equity$41.97M$45.15M$48.41M$51.87M$56.15M$58.74M$59.60M$60.30M
Net debt$71.53M$74.23M$74.61M$67.16M$69.64M$71.34M$70.16M$70.91M
Shares outstanding404.75M401.17M398.91M396.91M394.45M392.01M388.68M381.48M
Cash flow statement
Operating cash flow$3.49M$2.22M$949,000$3.43M$2.68M$297,000$1.29M-$413,000
Capital expenditure$245,000$298,000$373,000$33,000$559,000$309,000$266,000$1.06M
Free cash flow$3.24M$1.92M$576,000$3.40M$2.12M-$12,000$1.03M-$1.47M
Investing cash flow-$295,000-$507,000-$753,000-$197,000-$514,000-$554,000-$115,000-$1.20M
Financing cash flow-$1.27M-$1.21M-$1.14M-$944,000-$1.70M-$806,000-$1.26M-$893,000
Depreciation & amortization$2.20M$2.30M$2.15M$2.07M$2.10M$2.10M$1.81M$2.16M
Stock-based compensation$335,000$350,000$325,000$382,000$382,000$549,000$547,000$278,000

Free plan shows the latest 8 periods; Pro shows all 63 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.